Updated:
Australis Capital
Australis Capital invests in the US cannabis industry through equity, debt, and other securities in public and private companies. Investments include...
Overview
Australis Capital invests in the US cannabis industry through equity, debt, and other securities in public and private companies. Investments include financings for royalties and distribution streams, as well as control stake acquisitions. Australis Capital has made 3 investments, including a January 2019 investment in Folium Biosciences, and 1 portfolio exit, Green Therapeutics, in March 2021.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
Las Vegas
Corporate office
Las Vegas, United States
Frequently asked questions
Who runs investment decisions at Australis Capital?
No named principals or investment committee members are disclosed in public materials.
Does Australis Capital participate in fund commitments or only direct deals?
Public information shows a focus on direct early-stage and PIPE transactions.
What investment stages does Australis Capital typically target?
The firm lists early-stage startup and PIPE activity.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: